Educational Series: Cancer immunotherapy adverse reactions in primary care

This review is intended as an educational resource for primary healthcare professionals who encounter patients with suspected immune-related adverse reactions (irARs) to immune checkpoint inhibitor (ICI) therapy. It reviews the impact of irARs across organs, typical clinical presentations and work-up, and the typical management strategies for common and/or significant irARs.

Please login below to download this issue (PDF)